Coinbase Global: A New Buy Rating and Price Target from Rosenblatt In a recent research note, Rosenblatt Securities analyst Chris Brendler initiated coverage on Coinbase Global (COIN) with a Buy rating and a price target of $305. This news has sent waves of excitement through the crypto community, as Coinbase is one of the most…
Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Lifecore Biomedical, Inc. On March 16, 2025, Bronstein, Gewirtz & Grossman, LLC, a leading securities fraud class action law firm, announced that it is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. (Lifecore or the Company) (NASDAQ: LFCR). The investigation concerns whether Lifecore…
Envista’s Impressive Prospects for 2025: A Closer Look at the Implants Segment and Clear Aligners Envista (NVST) is gearing up for an exciting future, with its largest business unit, the Implants segment, poised for positive sales expansion in the coming quarters. This promising outlook is driven by the segment’s robust brand strength and the favorable…
A New Twist in the ETF Industry: TRUMP Meme Tokens Mixed with Low-Volatility Assets Introduction Recently, a new ETF filing has caught the attention of investors and meme enthusiasts alike. The proposed product aims to capitalize on the popularity of TRUMP meme tokens, while also incorporating low-volatility assets such as US government debt and money…
Exciting News from Endo, Inc.: Post Hoc Analysis of XIAFLEX® in Peyronie’s Disease at SESAUA In the bustling town of Malvern, Pennsylvania, on March 12, 2025, Endo, Inc. (NDOI) made headlines with an announcement that left many in the medical community buzzing. The pharmaceutical giant revealed that they would be sharing intriguing findings from a…
NS Pharma’s Exciting New Breakthrough: A Game-Changer in the Pharmaceutical Industry Paramus, N.J., March 10, 2025 – In a groundbreaking announcement, NS Pharma, Inc., a subsidiary of Nippon Shinyaku Co., Ltd., has unveiled its latest discovery in the realm of pharmaceuticals. This innovative development, which promises to revolutionize the way we approach medical treatments, has…
The First Inflation Report of 2025: A Closer Look Rising Prices and Hotter Than Expected Numbers Oh, the joys of adulting! Just when you thought you had a handle on your finances, along comes the first inflation report of 2025 with some not-so-great news. The report revealed a 3% increase in the Consumer Price Index…
Understanding Your Options After Suffering Losses from ESSA Pharma Inc. (EPIX) If you’re among the many investors who have experienced losses due to ESSA Pharma Inc.’s (EPIX) recent stock performance, you might be wondering what steps you can take under the federal securities laws. In this blog post, we’ll provide you with valuable information that…
